T follicular helper (Tfh) cells contribute to the establishment of humoral immunity by controlling the delivery of helper signals to activated B cells; however, Tfh development must be restrained, as aberrant accumulation of these cells is associated with positive selection of self-reactive germinal center B cells and autoimmunity in both humans and mice. Here, we show that TGF-b signaling in T cells prevented Tfh cell accumulation, selfreactive B cell activation, and autoantibody production. Using mice with either T cellspecific loss or constitutive activation of TGF-b signaling, we demonstrated that TGF-b signaling is required for the thymic maturation of CD44 + CD122 + Ly49 + CD8 + regulatory T cells (Tregs), which induce Tfh apoptosis and thus regulate this cell population. Moreover, peripheral Tfh cells escaping TGF-b control were resistant to apoptosis, exhibited high levels of the antiapoptotic protein BCL2, and remained refractory to regulation by CD8 + Tregs. The unrestrained accumulation of Tfh cells in the absence of TGF-b was dependent on T cell receptor engagement and required B cells. Together, these data indicate that TGFb signaling restrains Tfh cell accumulation and B cell-associated autoimmunity and thereby controls self-tolerance.
Introduction

CD4
+ T lymphocytes have been known for decades to play a crucial role in helping B cells produce antibodies (1) . More recently, among CD4 + T cells, T follicular helper (Tfh) cells have been described as a distinct subset with specialized helper functions. They colocalize with antigen-specific B cells within germinal centers (GCs), transient structures located within B cell follicles of secondary lymphoid tissues where somatic hypermutation of Ig variable region genes and selection of high affinity B cell clones occurs (2) (3) (4) . Tfh cells are phenotypically defined by their high expression of chemokine receptor CXCR5 that promotes their migration to the B cell follicles as well as high surface levels of programmed death 1 (PD-1) (5, 6) . Furthermore, Tfh cells express various receptors such as inducible T cell costimulator (ICOS), B and T lymphocyte attenuator (BTLA), and CD40L that are important for their development and/or function (2) . They also produce cytokines including IL-21, which promotes B cell maturation, survival, isotype switching, and affinity maturation (7) , and IL-4 or IFN-γ that can dictate isotype class switching to the appropriate Ig isotype tailored for protective immunity (8) . B cell lymphoma 6 (BCL6) protein, a transcriptional repressor, plays a key role in programming Tfh cell differentiation (9) (10) (11) .
Tfh cells normally differentiate from naive CD4 + T cells following immunization or infection. However, unrestrained accumulation of Tfh cells is associated with loss of B cell tolerance, development of autoantibodies, and autoimmune disorders in both humans and mice (12) (13) (14) (15) . Preventing the development of Tfh cells that normally expand in a T cell autonomous manner in the autoimmune-prone sanroque mouse model ameliorates autoantibody-related pathology (16) . Collectively, these studies point to the importance of preventing unrestrained accumulation of Tfh cells. CD4 + T cell subset differentiation is known to be highly influenced by the cytokine environment that can either enhance or repress their development. Both IL-6 and IL-21 have been described as cytokines capable of enhancing Tfh differentiation (2) . However, with the recent exceptions of IL-2 and IL-10 that were shown to partially restrain Tfh cell differentiation in an infection and immunization setting, respectively (17, 18) , no cytokine has been associated with controlling the spontaneous accumulation of Tfh cells observed in autoimmune diseases. CD8 + T regulatory cells (CD8 + Tregs) have been reported to prevent the unrestrained development of Tfh cells by inducing their apoptosis after interaction with Qa-1/ peptide complex on the surface of Tfh cells, in a TCR-dependent manner (19, 20) . Impairing the regulatory activity of CD8 + Tregs results in autoimmunity (20) , while adoptive transfer of CD8 + Tregs is sufficient to reduce the number of Tfh cells and blunt the development of rheumatoid arthritis in mice (21) , underlining the physiological relevance of CD8 + Treg-mediated control of Tfh cells. These regulatory cells represent 3% to 5% of peripheral CD8 + T cells, are thought to develop in the thymus (19, 22) , and are characterized by the surface expression of CD44, CD122, and Ly49. In addition to CD8 + Tregs, FOXP3-expressing CD4 + T cells that have coopted a CXCR5 + phenotype have been proposed to limit the size of the Tfh cell population and GC reactions in response to immunization (23) (24) (25) (26) . These T follicular regulatory (Tfr) cells originate from thymic-derived FOXP3 + Tregs and coexpress BCL6 but at lower levels than Tfh cells (23) (24) (25) (26) . Thus, regarding the aggressive autoimmune phenotype associated with the spontaneous accumulation of Tfh cells, one challenge of broad interest is to identify factors that directly control Tfh homeostasis and/or the development of the cellular T lymphocyte populations charged with their regulation.
T follicular helper (Tfh) cells contribute to the establishment of humoral immunity by controlling the delivery of helper signals to activated B cells; however, Tfh development must be restrained, as aberrant accumulation of these cells is associated with positive selection of self-reactive germinal center B cells and autoimmunity in both humans and mice. Here, we show that TGF-β signaling in T cells prevented Tfh cell accumulation, self-reactive B cell activation, and autoantibody production. Using mice with either T cell-specific loss or constitutive activation of TGF-β signaling, we demonstrated that TGF-β signaling is required for the thymic maturation of CD44
+ regulatory T cells (Tregs), which induce Tfh apoptosis and thus regulate this cell population. Moreover, peripheral Tfh cells escaping TGF-β control were resistant to apoptosis, exhibited high levels of the antiapoptotic protein BCL2, and remained refractory to regulation by CD8 + Tregs. The unrestrained accumulation of Tfh cells in the absence of TGF-β was dependent on T cell receptor engagement and required B cells. Together, these data indicate that TGF-β signaling restrains Tfh cell accumulation and B cell-associated autoimmunity and thereby controls self-tolerance.
The ability of TGF-β signaling to contain spontaneous Tfh accumulation was confirmed in adult mice expressing a dominantnegative (DN) form of the TGF-β type II receptor specifically in their T cells (TGF-βR-DN) that attenuates TGF-β signaling leading to a progressive autoimmune syndrome that is fatal at approximately 24 weeks of age compared with 3 weeks for TGF-βR-KO mice (32) . We observed a gradual accumulation of Tfh cells (Figure 1 , G and H) and GC B cell development (Figure 1 , I and J) in both the spleen and pLNs from TGF-βR-DN mice ruling out additional effects of TGF-β signaling on early peripheral colonization of an empty niche by T cells that could contribute to the unrestrained Tfh development observed in 2.5-week-old TGF-βR-KO mice. Thus, this first set of data reveals that TGF-β signaling regulates the spontaneous accumulation of Tfh cells and subsequent loss of B cell tolerance.
Sustained late-stage maintenance of Tfh cells following peptide immunization. Next, we sought to investigate whether TGF-β exerts a similar repressive effect on Tfh cell homeostasis following foreign peptide immunization. As TGF-βR-KO mice succumb to an autoimmune syndrome within 3 weeks of age, we immunized TGF-βR-DN mice with KLH in CFA. Four-week-old TGF-βR-DN mice were chosen before they accumulated spontaneous Tfh cells ( Figure 1G ). As previously reported in mice immunized with KLH peptide in CFA and treated with TGF-β blocking antibody (33), a similar frequency of Tfh cells and GC B cells was observed at day 7 after immunization between TGF-βR-DN and TGF-βR-WT mice implying that TGF-β did not affect Tfh differentiation (Figure 2 , A and B). However, 2 weeks later, while the Tfh cell pool had significantly contracted in the draining lymph nodes (dLNs) of WT mice, a significant population of Tfh cells remained detectable in the dLNs of TGF-βR-DN mice in response to KLH/CFA immunization ( Figure 2, A and B ). In line with this maintenance of Tfh cells, we also observed a greater induction of GC B cells ( Figure 2C ) and a higher IgG2a KLHspecific antibody titer in the blood of TGF-βR-DN mice as compared with TGF-βR-WT mice ( Figure 2D ). Thus, in addition to repressing the spontaneous accumulation of Tfh cells and preventing the development of autoreactive B cells, TGF-β signaling in T cells also regulates the size of the Tfh subset as well as the B cell response following protein immunization.
Peripheral CD8 + Tregs decrease in the absence of T cell-specific TGF-β signaling. There are several explanations for the spontaneous accumulation of Tfh cells in the absence of TGF-β signaling control. The absence of TGF-β signaling could affect T cell populations involved in restraining Tfh cell expansion. Alternatively, it is possible that self-reactive TGF-βR-deficient T cells preferentially differentiate into Tfh cells. Finally, T cell intrinsic mechanisms might exist that are disrupted in the absence of TGF-β signaling leading to preferential accumulation of Tfh cells.
Thus, we addressed our first hypothesis by examining the development of T cell subsets implicated in repressing Tfh cells. Recently, CD4 + T cells expressing FOXP3, CXCR5, and PD-1 (Tfr cells) have been described as regulating Tfh cells in immunization-induced GCs (24) (25) (26) . As TGF-β has been reported as contributing to the induction and maintenance of FOXP3 in CD4 + T cells (34, 35 ) and a reduced frequency of Tfr cells has been shown to aggravate lupuslike disease (36), we first analyzed the Tfr cell compartment using TGF-βR-KO mice expressing FOXP3 gfp . Among CD4 + T cells that were double-positive for CXCR5 and PD-1, the frequency of Tfr cells
In this study, we reveal that TGF-β is a crucial cytokine to prevent the uncontrolled accumulation of Tfh cells. Mice deprived of TGF-β signaling in their T cells spontaneously accumulated Tfh cells in a TCR-and B cell-dependent manner leading to loss of B cell tolerance, antinuclear autoantibody production, and IgG complex deposition in the kidney. We found that not only was TGF-β signaling required for CD8 + Treg thymic development but that Tfh cells lacking TGF-β signaling had reduced sensitivity to apoptosis and were refractory to CD8 + Treg-mediated suppression. Collectively, our results demonstrate the ability of TGF-β signaling to act in a T cell intrinsic manner to restrain Tfh cell accumulation and B cell-associated autoimmunity revealing a novel mechanism in the control of self-tolerance.
Results
TGF-β signaling in T cells prevents aberrant accumulation of Tfh cells.
We and others have previously demonstrated that Tgf-βR2 fl/fl CD4-Cre (TGF-βR-KO) mice deprived of TGF-β signaling, specifically in their αβ T cells, succumb to aggressive, early onset autoimmunity, including lymphocyte infiltration of organs and high levels of autoantibodies despite the fact that B cells are untouched by the mutation (27, 28) . This phenotype, with aspects reminiscent of systemic lupus erythematosus (SLE), was also observed in mice totally deficient in TGF-β (29) . In TGF-βR-KO mice, we observed high levels of circulating IgG double-stranded (ds) DNA and glomerular deposition of IgG immune complexes as compared with healthy littermate controls ( Figure 1, A Figure 1A ; supplemental material available online with this article; doi:10.1172/JCI76179DS1). Spontaneously accumulating Tfh cells expressed the GC-associated maker GL7, as well as high levels of ICOS, BTLA, CD40L, and IL-21, affirming their Tfh credentials (Supplemental Figure 1, B and D) . However, surface expression of these B cell-activating molecules as well as the production of the B cell-activating cytokine IL-21 were clearly increased in Tfh cells from TGF-βR-KO mice compared with that from TGF-βR-WT mice as has been observed in B cell-associated autoimmunity diseases in humans (30) . Moreover, in agreement with high levels of IgG2 in the blood of TGF-βR-KO mice (28), we noticed that Tfh cells that developed in an unrestrained manner in the absence of TGF-β control massively produced IFN-γ in contrast to basal Tfh cells from TGF-βR-WT mice (Supplemental Figure 1C) . Furthermore, we did not detect IL-17 (data not shown), a cytokine that has been implicated in pathogenic GC formation in some circumstances (31) . jci.org Volume 124 Number 10 October 2014 CD44 hi , CD122, and Ly49 that have been shown to repress spontaneous development of Tfh cells by inducing their apoptotic death, thereby efficiently contributing to the control of autoimmune diseases in both mice and humans (20, 21, 37) . While Figure 4B ). To definitively confirm a direct effect of TGF-β signaling on CD8 + Treg thymic development, we next analyzed the origin of the CD8 + Treg thymocytes using irradiated Rag-KO mice reconstituted with equal parts BM from congenic TGF-βR-WT mice and TGF-βR-KO mice; we found that more than 90% of the CD8 + Treg thymocytes were derived from the TGF-βR-WT BM whereas CD8 + T cells were equally derived from the 2 BM origins ( Figure 4C) . Surprisingly, in contrast with the large amount of CD8 + Tregs at the periphery of TGF-βR-CA mice, we observed a decrease in the CD8 + Treg proportion and number in the thymus of TGF-βR-CA mice compared with TGF-βR-WT mice ( Figure 4 , A and D). However, this discrepancy can be explained by analysis of the frequency of signal joint TCR excision circles (sjTRECs) in the peripheral cell population implying an exacerbated thymic export of mature CD8 + Tregs in TGF-βR-CA mice compared with TGF-βR-WT mice, whereas sjTREC content in total CD8 + T cells was unchanged ( Figure 4E ). Taken together, these data indicate TGF-β as a crucial cytokine for the development of CD8 + Tregs facilitating their rapid thymic differentiation to increase the peripheral number of these cells to restrain the Tfh cell population.
Aberrantly accumulating Tfh cells lacking TGF-βRII are refractory to CD8
+ Treg control. In the absence of TGF-β signaling control, there is a clear delay in the constitution of the CD8 + Treg pool. Thus, we next investigated whether the large number of Tfh cells observed in the absence of TGF-β signaling in T cells was due to the defect in CD8 + Treg development. To address this hypothesis, we generated mixed BM chimera mice by reconstituting irradiated Rag-KO mice with BM (1:1) from both TGF-βR-KO mice and congenic TGF-βR-WT mice and analyzed them for the presence of Tfh mice ( Figure 3 , C and D). Moreover, we found a 1.5-2-fold increase in CD8 + Tregs in LSL-TβRI CA CD4-Cre (TGF-βR-CA) mice whose T cells express a constitutive active form of the TGF-β receptor (38) , as compared with TGF-βR-WT mice (Figure 3, C and E), which supports the direct contribution of TGF-β signaling in T cells on CD8 + Treg homeostasis. Consequently, the ratio of the number of CD8 + Tregs to Tfh cells in TGF-βR-KO and in TGF-βR-CA mice was more than 60-fold lower and 8-times higher, respectively, compared with control mice ( Figure 3F) .
TGF-β regulates thymic development of CD8 + Tregs. We failed to observe any difference in peripheral CD8 + Treg apoptosis using annexin/7-AAD staining and peripheral CD8 + Treg proliferation using BrdU addition to drinking water between TGF-βR-CA mice and TGF-βR-WT mice (data not shown). Therefore, we next analyzed the effects of TGF-β signaling on CD8 + Treg thymic development. In complete agreement with the lack of peripheral CD8 + T cell expansion. It is also noteworthy that no aberrant accumulation of TGF-βR-WT Tfh cells was observed in the BM chimera ( Figure 5, A and B) , ruling out any cytokine bystander effect from the well-known inflammatory environment provided by the TGF-βR-KO T cells (27, 28) . Similarly, TGF-βR-DN Tfh cells were highly represented 3 weeks after immunization of irradiated cells and their BM origins. The CD8 + Treg compartment was fully reconstituted mainly from TGF-βR-WT BM cells as illustrated in Figure 4C . Strikingly, the CD4 + T cell compartment derived from the BM of TGF-βR-KO mice was highly enriched in Tfh cells in the presence of TGF-βR-WT BM-derived cells ( Figure 5, A and B) , strongly suggesting that aberrantly accumulating Tfh cells lacking TGF-βRII were refractory to TGF-βR-WT CD8 + Treg control and implicating a T cell intrinsic mechanism permitting spontaneous Tfh cell accumulation in the absence of TGF-β control. Furthermore, the ratio of the total number of Tfh cells to non-CD4 + Tfh Rag-KO mice previously reconstituted with mixed BM from TGF-βR-WT and TGF-βR-DN mice (Supplemental Figure 2, A and B) . These data firmly establish an intrinsic effect of TGF-β signaling in repressing uncontrolled Tfh cell accumulation and shows that Tfh cells escaping TGF-β control are refractory to regulatory cells. Spontaneous Tfh cell accumulation occurs in a TCR-and B-cell dependent manner. We next investigated the mechanisms that could be involved in the uncontrolled Tfh cell accumulation and autoreactive B cell activation in the absence of TGF-β signaling. We first analyzed whether self-reactive TGF-βR-deficient T cells might preferentially become Tfh cells either by spontaneous activation due to tonic TCR signaling irrespective of TCR specificity or alternatively from preferential activation of self-reactive CD4 + T cells. To discriminate between these two scenarios, we bred TGF-βR-KO mice onto TEa TCR transgenic mice (39) . In the latter mice, a transgene encoding a Vα2 Because Tfh cells from TGF-βR-KO mice cannot be kept in check by the regulatory effect of WT CD8 + Tregs known to regulate Tfh cells by inducing their apoptosis, we finally investigated the survival ability of Tfh cells responding or not to TGF-β signaling. We looked at apoptosis in Tfh cells using annexin V and 7-AAD costaining. In line with a previous report of increased sensitivity to apoptosis in TGF-βR-KO mice (44), we demonstrated that peripheral CD4 + non-Tfh cells from TGF-βR-KO mice were more susceptible to apoptosis compared with WT controls ( Figure 7C ). However, in clear contrast, TGF-βR-KO Tfh cells were significantly less inclined to apoptosis than Tfh cells from TGF-βR-WT mice ( Figure 7C ). In addition to specificity for the Tfh subset, this resistance to apoptosis in the absence of TGF-β signaling seemed to involve intrinsic mechanisms, since we observed that TGF-βR-WT Tfh cells remained more sensitive to apoptosis than TGF-βR-KO Tfh cells in mixed BM chimera mice (data not shown). Consistent with their apoptosis resistance, we found high levels of the antiapoptosis protein BCL2 in TGF-βR-KO Tfh cells as compared with those from TGF-βR-WT mice ( Figure 7D ) and no difference in the levels of the proapoptotic molecules, Bim or Fas (data not shown). Collectively, these data demonstrate that the Tfh cells escaping TGF-β control have clearly reduced sensitivity to apoptosis, implying their resistance to apoptosis as a T cell intrinsic mechanism promoting their aberrant accumulation and the associated rupture in B cell tolerance.
Discussion
New B cell receptor specificities, including those with autoreactivity, arise continuously during the GC reaction (45) (46) (47) . Aberrant accumulation of Tfh cells has been associated with positive selection of self-reactive GC B cells and autoimmunity in both mice and humans (30, 48) . Elucidating the mechanisms that prevent development of high-affinity antibodies to dsDNA and self-proteins is central to understanding autoimmune diseases such as lupus erythematosus, rheumatoid arthritis, and myasthenia gravis and hence, to developing specific therapeutic approaches. We showed here that in the absence of TGF-βR signaling in T cells, Tfh cells spontaneously accumulated in an uncontrolled manner accompanied by B cell activation, autoantibody production, and immune complex deposition in the kidney. Mechanistically, Tfh cell accumulation in the absence of TGF-β signaling was T cell intrinsic, dependent on TCR engagement, required B cells, and was associated with improved survival, increased levels of antiapoptotic BCL2, and resistance to CD8 + Treg regulation. We also demonstrated an essential role for TGF-β signaling in the thymic development of CD8 + Tregs. Thus, this study reveals the importance of T cell control by TGF-β to prevent the aberrant accumulation of Tfh cells and development of B cell autoimmunity. some Tfh cells are spontaneously generated in nonimmunized mice, likely in response to environmental antigens or self-antigens.
Compared with other CD4 + T cells, we and others have found that these cells are endowed with a higher proliferative ability (43), but we also show here that they are more susceptible to apoptosis. These cells accumulate with age in humans (54) and could be involved in autoantibody production. Supporting this idea, autoantibodies are known to accumulate in mice and humans with age (55, 56) . Though the role of spontaneously developed Tfh cells remains to be clearly identified, it seems clear that aberrant accumulation of Tfh cells has been associated with loss of B cell tolerance, massive development of autoantibodies, and autoimmune disorders in both humans and mice (15, 48) . We propose that control of the size of these spontaneously developed Tfh cells relies on a tight equilibrium between cell cycling and apoptosis maintaining a low number of spontaneously developed Tfh cells to avoid loss of B cell tolerance and that TGF-β is at the core of this equilibrium. We revealed that in the absence of TGF-β control, a large part of the spontaneously developed cells escape apoptosis and noxiously accumulate in the organism. Interestingly, contraction of CD8 + effector T cells, an apoptotic phenomenon crucial to protect the organism from tissue damage due to exacerbated immune responses, behaves similarly, employing a TGF-β-mediated mechanism to repress BCL2 expression (57) . Thus, one role for TGF-β in maintaining organism integrity could be controlling, by apoptosis, the size of the T lymphocyte populations whose uncontrolled expansions are toxic to the organism. In addition to apoptosis resistance, it is possible that other factors such as the high levels of ICOS observed in TGF-βR-KO T cells could contribute to the massive Tfh cell development regarding the role ICOS signaling plays in the development of Tfh cells (42) . However, this contribution should be minor since we failed to find aberrant accumulation of TGF-βR-WT Tfh in TGF-βR-KO:TGF-βR-WT mixed BM chimera mice.
The origin of TGF-β controlling Tfh cell homeostasis remains an open question, regarding the ubiquitous expression of this cytokine within the organism. However, it is possible that Tfh cells Our findings, in both TGF-βR-KO and TGF-βR-DN mice, indicated that T cells, either escaping or modulating TGF-β control, respectively, could accumulate spontaneously as Tfh cells. It is notable that these 2 mouse models have been associated with high levels of inflammatory cytokines such as IFN-γ (28, 49), which is known to lead to BCL6 overexpression and excessive development of Tfh cells (43) . However, our work rules out any bystander cytokine action on Tfh cell population control in these mouse models, and thus underlines a direct effect of TGF-β on T cells to control Tfh cell homeostasis. Although we have not directly assessed the TCR repertoire and specificity of the aberrantly expanded Tfh cells in TGF-βR-KO mice, our finding that T cells lacking TGF-β signaling were unable to develop into Tfh cells when their TCR was substituted for a transgenic TCR specific for a defined foreign antigen strongly argues for T cell autoreactivity to self-peptides as was suggested for the global CD8 + and CD4 + T cell populations (50). Germ-free mice have been found to have a lower frequency of Tfh cells and reduced autoantibody titers in an autoimmune arthritis model (51); however, we excluded reactivity against the microbiota since TGF-βR-KO mice placed under a large spectrum of antibiotics, before and after birth, spontaneously develop large numbers of Tfh cells (data not shown). However, as Tfh cells tend to be derived from T cells binding peptide/MHC with a high affinity (52) , consistent with the observation that prolonged TCR engagement during viral persistence predisposes activated T cells towards Tfh development (53) , it is possible that TGF-β signaling might play an intrinsic role in preventing unwanted Tfh cell accumulation by heightening the antigen affinity required for TCR activation. In line with this hypothesis, we have found the ability of TGF-β to restrain T cell reactivity towards low-affinity self-antigen is the result of altered TCR signaling thresholds (unpublished observations, Marie and Hennino).
Our work suggests that TGF-β limits the size of the already established Tfh cell population. Thus, we propose that TGF-β prevents the aberrant accumulation of Tfh cells that spontaneously accumulate during life in response to self-antigen. It is known that peptide that noncovalently binds to mature TGF-β and controls its activity (data not shown). Both cell subsets would represent attractive candidates as the GC source of TGF-β. In addition to affecting the sensitivity of Tfh cells to apoptosis, our work revealed that TGF-β signaling in T cells is also required for the thymic development of CD8 + Tregs, known to regulate the size of Tfh cells by inducing their apoptosis (19, 21) . Interestingly, other regulatory cell populations that also recognize self-peptides such as FOXP3 + Tregs, CD8αα + intraepithelial lymphocytes, and invariant NKT (iNKT) cells (60) (61) (62) , differentiate in the thymus in a TGF-β-dependent manner, emphasizing a fundamental role for TGF-β in the differentiation of self-reactive regulatory cells. Though the exhibit a difference in sensitivity to TGF-β during their life. As BCL6 has been shown to be a repressor of TGF-β signaling (58), recently differentiated Tfh cells might survive the proapoptotic effect of TGF-β and later, when their BCL6 levels are reduced (59), they might become susceptible to TGF-β-induced apoptosis. Indeed, a small population of Tfh cells remains long after the immune response and maintains BCL6 at low levels (59) . In response to immunization or infection, as suggested for CD8 + T cells, a large wave of TGF-β produced by the organism and observed after day 8-10 could increase TGF-β signaling and thus Tfh sensitivity to apoptosis (57 Institute, NIH, Bethesda, Maryland, USA) (32 negative selection followed by cell sorting to high purity. Mouse immunization. Mice were injected subcutaneously in the tail base with 2 × 50 μl of keyhole limpet hemoctyanin (KLH; 0.5 mg/ml; Calbiochem) emulsified in an equal volume of complete Freund adjuvant (CFA; 1 mg/ml; Sigma-Aldrich). Control mice were injected with CFA alone. Mice were sacrificed, and the draining inguinal lymph nodes were examined on day 7 or 21 following immunization.
Antibodies and flow cytometry. Cells were preincubated with anti-CD16/32 and stained for 30 minutes at 4°C with the following antibodies. CD4 (RM 4-5), PD-1 (RPMI-30), B220 (RA3-6B2), ICOS (7E.17G9), BTLA (8F4), GL-7 (GL-7), CD8 (53-6.7), Ly49C/I/F/H (14B11), CD122 (TM-b1), CD40L (MR1), FOXP3 (FJK-16s), CD90.1 (Thy1.1), Vα2 (B20.1), Vβ6 (RR4-7), IL-21 (FFA21), and IFN-γ (XMG1.2) were purchased from eBioscience; CXCR5 (2G8), CD44 (1M7), CD3 (145-2C11), CD19 (1D3), CD95 (J02), BCL6 (K112-91), BCL2 (3F11), and Ki-67 (B56) were purchased from BD Biosciences. Biotinylated mouse TGF-βRII was purchased from R&D Systems. Streptavidin PeCy7, FITC, and APC (BD Biosciences) were also used. Flow cytometric analysis was carried out using a CyAn (Beckman Coulter) or BD Fortessa (BD Biosciences), and analysis of cells was performed using FlowJo software (Tree star Inc.). Fluorescence minus one (FMO) controls were used to set positive staining gates. For apoptosis staining, cells were incubated at 37°C for 3 hours in RPMI media without fetal calf serum prior to staining with annexin V and 7-AAD (BD Biosciences) in appropriate binding buffer (BD Biosciences) according to the manufacturer's instructions. For intracellular cytokine staining, cells were stimulated with 500 ng/ml PMA (Sigma-Aldrich) and 500 ng/ml ionomycin (Sigma-Aldrich) for 3 hours in the presence of Golgiplug (BD Pharmingen). Cells were fixed and permeabilized using the BD cytofix/cytoperm kit (BD Pharmingen). For intranuclear staining, the FOXP3 staining kit was used (eBioscience).
Immunofluorescence histology. Kidney tissues were embedded in Tissue-Tek OCT compound (Sakura Finetek) and snap frozen over liquid nitrogen. Sections (6 μm) were cut with a Leica X cryostat onto Poly-Prep slides (Sigma-Aldrich). Slides were fixed in cold acetone/ethanol (3:1) and blocked with 1% BSA (Sigma-Aldrich). Goat mechanisms by which TGF-β controls the development of all of these regulatory subsets are not completely understood, some similarities can be pointed out. Similar to iNKT cells, it is likely that the development of CD8 + Tregs undergoes different development stages based on CD44 and CD122 expression that involves both IL-15 and TGF-β (60, 63 
CD8
+ Tregs, though the acquisition of Ly49 is known to be independent of IL-15 (64) . Our data suggests that the development of CD8 + Tregs is blocked at the CD44 + CD122
+ stage in the absence of TGF-β signaling where precursors massively accumulate and fail to rapidly acquire Ly49 implying that the optimal acquisition of Ly49 is under TGF-β control. Thus, TGF-β would accelerate the differentiation/maturation process of CD8 + Tregs. In TGF-βR-KO mice, we observed a delay in CD8 + Treg development. Very few CD8 + Tregs were produced in the thymus during the first 2 weeks of the animals, whereas similar numbers to that observed in TGF-βR-WT mice were present after 2 weeks of age. These data suggest that either other factors could gradually take over in the absence of TGF-β signaling control or that TGF-β signaling contributes only to the early development of CD8 + Tregs. Interestingly, such a delay in the thymic development of FOXP3 + regulatory cells in the absence of TGF-β control has also been reported but identification of contributing factors remains elusive (62) . Thus, we propose that TGF-β enhances the generation of regulatory cell populations in the thymus to allow their rapid presence at the periphery and allow early control of the homeostasis of putative autoreactive lymphocytes. However, it is important to note that in addition to their resistance to apoptosis, Tfh cells escaping TGF-β control could also be refractory to regulatory mechanisms mediated by FOXP3 +
CD4
+ Tfr cells or other regulatory cell populations similar to total CD4 + T cells lacking the TGF-β receptor that have been described as being refractory to FOXP3 + CD4 + T cells (28) . Whether TGF-β production by these regulatory cell populations could also contribute to controlling autoreactive Tfh cells, and thus B cell autoreactivity, should be the focus of future investigations.
In sum, the data reported here demonstrate that TGF-β signaling in T cells is crucial to restrain the size of the Tfh cell population, which, when left unchecked, leads to a break in B cell tolerance. By increasing their sensitivity to apoptosis, TGF-β exerts an intrinsic cellular mechanism preventing the damaging accumulation of Tfh cells. Given that an increased frequency of Tfh cells has been shown to positively correlate with autoantibody production in patients suffering from SLE (13) , and TGF-β production is deficient in SLE patients (65) and lupus-prone (New Zealand Black and White) F 1 mice (66), the modulation of Tfh cells by TGF-β might represent a promising therapeutic intervention in diseases associated with B cell autoreactivity. Taken together, these results highlight a new role for TGF-β in CD4 + T cell subset development with important implications for understanding the loss of B cell tolerance mechanisms.
Methods
Mice. fl/fl CD4-Cre (TGF-βR-KO) mice were previously reported (28). Cre-negative littermates were used as WT controls. DN-TGF-βRII (TGF-βR-DN) mice were provided by Ronald Gross (National Cancer jci.org Volume 124 Number 10 October 2014 10% FCS, 2 mM L-glutamine, 100 units/ml penicillin, and 100 mg/ml streptomycin) with 1 × 10 6 splenocytes in 96-well flat bottom plates. ) were injected intravenously into Rag-KO recipient mice that had been irradiated (8 Gy). Mice were analyzed 5 to 6 weeks after reconstitution.
ELISA. IgG-specific dsDNA was detected using a commercially available ELISA kit according to the manufacturer's instructions and read at a wavelength of 450 nm (Alpha Diagnostic International). Values (U/ml) were automatically generated from a standard curve. For the antigen-specific ELISA, 96-well plates (Nunc) were coated overnight with 2 μg of KLH peptide, blocked with 1% BSA/PBST, and incubated with serial serum dilutions. Bound Ig was detected using anti-IgG2a (Invitrogen) directly labeled with streptavidin-HRP conjugate. Color was visualized by the addition of o-phenylenediamine dihydrochloride (OPD; Sigma-Aldrich). Absorbance at wavelength 490 nm was read using a microplate reader (Tecan), and OD values were compared.
Real-time PCR analysis. Signal joint TREC analysis to detect recent thymic emigrant status of peripheral T cells was performed as described (67) . Genomic DNA was isolated from FACS-sorted CD8 + Tregs using the QIAamp DNA Mini Kit (QIAGEN) according to the manufacturer's instructions. SjTREC and CD45 primers and probes with a FAM reporter dye and TAMRA quencher dye were used as published (68, 69) . A CD45 reference gene was used to correct for input genomic DNA of purified lymphocytes. A ROX internal reference dye (Invitrogen) was added to the mixture. The reaction was run on an ABI Prism 7000 Sequence Detection System (Applied Biosystems), and fold-change was calculated using the 2 -ΔΔCt method.
In 
